Orthopedic Executives See Encouraging Trends in 1Q24

orthopedic team collaboration

Most orthopedic companies enjoyed a buoyant 2023 marked by a stable operating environment and elevated growth rates. That momentum carried into the first quarter of 2024, as the public companies we cover grew in the mid-single-digits. Below, we present quotes from the leaders of those companies as they reflect on the first quarter’s...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us